Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
57 studies found for:    "Living Donors" | Open Studies
Show Display Options
Rank Status Study
21 Unknown  Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation
Condition: Kidney Transplant
Interventions: Biological: Zostavax (Live attenuated herpes zoster vaccine);   Biological: Placebo vaccine
22 Recruiting Perioperative Evaluation of Terlipressin Infusion During Living Donor Liver Transplantation on Incidence of Acute Kidney
Conditions: Acute Kidney Injury;   Liver Transplantation;   Terlipressin;   NGAL
Interventions: Drug: Terlipressin;   Drug: placebo
23 Recruiting Combined Blood Stem Cell and Human Leukocyte Antigen (HLA) Haplotype Match Living Donor Kidney Transplantation
Condition: Kidney Transplantation
Intervention: Procedure: Total Lymphoid Radiation with Donor hematopoietic stem Cell and Kidney Transplant
24 Unknown  Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes
Condition: Renal Transplantation
Intervention: Drug: TAIZ
25 Not yet recruiting The ONE Study ATDC Trial
Condition: Renal Failure, End Stage
Intervention: Biological: ATDC_Nantes
26 Recruiting Research Study of ATG and Rituximab in Renal Transplantation
Condition: Acute Kidney Injury
Interventions: Drug: ATG;   Drug: Rituximab;   Drug: Tacrolimus;   Drug: Sirolimus;   Drug: MMF
27 Unknown  A Comparison of Kidney Function After Nephrectomy in Living Donors Under Sevoflurane and Desflurane Anesthesia
Condition: Nephrectomy,Kidney Donation
Interventions: Drug: Sevoflurane;   Drug: desflurane
28 Recruiting Explore Transplant at Home: Improving Low-Income ESRD Patients' Transplant Knowledge
Condition: End Stage Renal Disease
Interventions: Other: Patient-Guided;   Other: Educator-Guided
29 Recruiting Vasodilator-induced Hypovolemia in Living Liver Donors
Conditions: CVP and SVV During Living Donor Hepatectomy;   Surgical Field Grade (Condition of Surgical Field; Bleeding, Tension of the IVC)
Intervention: Procedure: vasodilator induced hypovolemia
30 Recruiting Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver Transplantation
Condition: Pediatric Liver Transplantation
Intervention: Drug: Tacrolimus
31 Not yet recruiting Omega 3 Lipid Emulsions and Liver Transplantation
Condition: Reduction of Graft IR With Pretreatment of Omega 3
Intervention: Dietary Supplement: SMOFLipid
32 Unknown  Adrenal Function After Living Kidney Donation
Conditions: Addison Disease;   Hypoaldosteronism
Intervention: Procedure: Laparoscopic hand-assisted donor nephrectomy
33 Recruiting Incidence, Risk Factors, and Risk Model of Acute Kidney Injury After Liver Transplantation
Conditions: Renal Function;   Liver Transplantation
Intervention: Procedure: living donor liver transplantation
34 Recruiting Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs
Condition: Immune Tolerance
Intervention: Device: Immune tolerance
35 Recruiting Adequate Definition of Delayed Graft Function in Living and Deceased Donor Kidney Transplantation
Conditions: Deceased Donor Kidney Transplantation;   Living Donor Kidney Transplantation
Intervention: Procedure: kidney transplantation, living or deceased donor
36 Recruiting The ONE Study M Reg Trial
Condition: Renal Failure, End Stage
Intervention: Biological: Donor M reg (Mreg_UKR)
37 Recruiting RituxiMab INDuction in Renal Transplantation
Condition: Function of Renal Transplant
Interventions: Drug: Rituximab;   Drug: Tacrolimus;   Drug: Mycophenylate mofetil;   Drug: Hydrocortisone;   Drug: Prednisolone
38 Unknown  Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant
Conditions: Transplantation, Homologous;   Immunosuppression
Intervention: Drug: everolimus
39 Unknown  Trial of Rituximab Given Pre-Transplant to Sensitised Live Donor Kidney Recipients
Condition: Kidney Transplantation
Interventions: Drug: Rituximab;   Drug: Standard Care
40 Recruiting University of Minnesota Transplant Registry
Conditions: Transplant Recipient;   Transplant Donation
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-57) Show next page of results    Last Page
Indicates status has not been verified in more than two years